A device that generates nitric oxide gas to treat pulmonary hypertension
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
This study is working on a new portable device that makes nitric oxide gas to help people with pulmonary hypertension breathe better and feel more comfortable, making treatment easier and more affordable for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Inovodel, INC. NIH-funded |
| Lab location | 1 site (Bethany Beach, UNITED STATES) |
| Project ID | NIH-10845503 on NIH RePORTER |
What this research studies
This research focuses on developing a new device that generates nitric oxide gas, which is used to treat pulmonary hypertension (PH). Patients with PH often suffer from low oxygen levels and shortness of breath, leading to a reduced quality of life. The device aims to provide a more accessible and cost-effective way to deliver nitric oxide, which is currently only available in specialized medical settings. By creating a portable solution, the research seeks to improve treatment options for patients with this serious condition.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with pulmonary hypertension, particularly those who experience severe symptoms and have limited treatment options.
Not a fit: Patients with pulmonary hypertension who are already receiving effective treatment or those with contraindications to nitric oxide therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and treatment accessibility for patients with pulmonary hypertension.
How similar studies have performed: Previous research has shown promise in using nitric oxide for treating pulmonary hypertension, but this approach aims to innovate and simplify the delivery method, making it a novel endeavor.
Where this research is happening
Bethany Beach, UNITED STATES
- Inovodel, INC. — Bethany Beach, United States (Active)
Researchers
- Principal investigator: Lessing, Gary — Inovodel, INC.
- Study coordinator: Lessing, Gary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.